US loss of exclusivity · Cardiometabolic
Jardiance
Boehringer Ingelheim / Eli Lilly
2029
US generics from
2025
Today: 2026
2037
2025 worldwide sales
≈$9.9B
Date basis
Company guidance
US generics
Filed with the FDA
Medicare price
−66% from 2026
Pharma Patent Cliff
by readouts.io
Data checked 8 October 2026 ·
Full Jardiance timeline →